GlobalData’s “Transcatheter Therapeutics (TCT) 2009: Conference Review and Analysis” report is an essentially source of information and analysis on the happenings in Transcatheter Therapeutics (TCT) 2009, scheduled to be held from September 21-25, 2009 in San Francisco, US. The report provides key data and information on the products showcased in the conference. The report also provides answers to questions like: what are the emerging trends in the cardiovascular devices market? Which are the upcoming technologies and companies? Which sectors are expected to grow and why? What products are in pipeline and how would they impact sector growth? This report also provides an insight into key studies and trials being held, with up-to date results and analysis.
Scope
- The report covers information and analysis on product and technology launched at the conference.
- The report provides market size data and information on the cardiovascular devices market with information for seven categories - Cardiac Rhythm Management (CRM), cardiovascular monitoring and diagnostic devices, cardiovascular prosthetic devices, cardiovascular surgery, interventional cardiology, peripheral vascular devices and electrophysiology.
- Analysis and review of the key products and technologies within each segment and sub - segments that will impact the future of cardiovascular devices.
- Review of key industry trends and events which are likely to impact and change the dynamics of the global cardiovascular devices markets in the long run.
- In-depth analysis of the studies and clinical trials presented at the conference.
- List of key companies presenting at the conference with company and product profiles.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.
Reasons to buy
- Develop business strategies by understanding the trends shaping and driving the global cardiovascular devices market.
- Organize your sales and marketing efforts by identifying the prevalent and expected competitive landscape in different cardiovascular devices markets.
- Design and develop your product development, marketing and sales strategies by identifying the market segments poised for a strong growth.
- Identify key players who are best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What’s the next being thing in the cardiovascular devices market landscape? – Identify, understand and capitalize.
Scope
- The report covers information and analysis on product and technology launched at the conference.
- The report provides market size data and information on the cardiovascular devices market with information for seven categories - Cardiac Rhythm Management (CRM), cardiovascular monitoring and diagnostic devices, cardiovascular prosthetic devices, cardiovascular surgery, interventional cardiology, peripheral vascular devices and electrophysiology.
- Analysis and review of the key products and technologies within each segment and sub - segments that will impact the future of cardiovascular devices.
- Review of key industry trends and events which are likely to impact and change the dynamics of the global cardiovascular devices markets in the long run.
- In-depth analysis of the studies and clinical trials presented at the conference.
- List of key companies presenting at the conference with company and product profiles.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.
Reasons to buy
- Develop business strategies by understanding the trends shaping and driving the global cardiovascular devices market.
- Organize your sales and marketing efforts by identifying the prevalent and expected competitive landscape in different cardiovascular devices markets.
- Design and develop your product development, marketing and sales strategies by identifying the market segments poised for a strong growth.
- Identify key players who are best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What’s the next being thing in the cardiovascular devices market landscape? – Identify, understand and capitalize.
1 TABLE OF CONTENTS
1.1 LIST OF TABLES
1.2 LIST OF FIGURES
2 TRANSCATHETER CARDIOVASCULAR THERAPEUTICS (TCT) 2009 – CONFERENCE REVIEW AND ANALYSIS
2.1 Summary
2.2 Key Takeaways of TCT 2009
2.2.1 Drug Eluting Stents (DES) Pipeline
2.2.2 The Hybrid Cath Lab Operating Rooms (ORs)
2.2.3 Emerging Role of Genetics in Predicting Risk of Disease
3 TCT 2009 - INTERVENTIONAL CARDIOLOGY OUTLOOK
3.1 Market Profile
3.2 Competitive Landscape
3.3 Key Companies at TCT 2009
3.3.1 Boston Scientific Corporation
3.3.2 Abbott Vascular
3.3.3 Medtronic Inc
3.3.4 Cordis Corp.
3.3.5 Spectranetics
3.3.6 Cardiva Medical Inc
4 TCT 2009 - PERIPHERAL VASCULAR DEVICES OUTLOOK
4.1 Market Overview
4.2 Competitive Landscape
4.3 Key Companies at TCT 2009
4.3.1 Pathway Medical Technologies
4.3.2 Cook Medical Incorporated
4.3.3 Minnow Medical, Inc
4.3.4 Abbott Vascular
4.3.5 Terumo Corporation
4.3.6 Vascular Solutions Inc
5 TCT 2009 - PROSTHETIC HEART VALVES OUTLOOK
5.1 Market Overview
5.2 Key Companies at TCT 2009
5.2.1 Coherex Medical Inc
5.2.2 Evalve Inc
5.2.3 Mardil Inc
6 TCT 2009 – VENTRICULAR ASSIST DEVICES OUTLOOK
6.1 Market Overview
6.2 Key Companies at TCT 2009
6.2.1 BIOMED Inc.
6.2.2 CardiacAssist Inc.
7 OTHER COMPANIES AT TCT 2009
7.1 Morris Innovative
7.1.1 Company Profile
7.1.2 Product Profile
7.1.3 Clinical Trial
7.2 ProSolv CardioVascular
7.2.1 Company Profile
7.2.2 Product Presented at TCT 2009
7.3 TeraRecon, Inc.
7.3.1 Company Profile
7.3.2 Product Presented at TCT 2009
7.4 Ardian Inc.
7.4.1 Company Profile
7.4.2 Product Presented at TCT 2009
7.4.3 Clinical Trial
7.5 PLC Systems Inc.
7.5.1 Company Profile
7.5.2 Product Presented at TCT 2009
7.5.3 Clinical Trial
7.6 Vascular Solutions
7.6.1 Company Profile
7.6.2 Product Presented at TCT 2009
8 APPENDIX
8.1 GlobalData Research Methodology
8.2 Secondary Research
8.3 Primary Research
8.4 Models
8.5 Forecasts
8.6 Expert Panel Validation
8.7 Currency Conversion
8.8 Contact Us
8.9 Disclaimer
1.1 LIST OF TABLES
Table 1: Interventional Cardiology, Global, Revenue ($m), 2000-2015
Table 2: TAXUS Express Horizon’s AMI Trial, Two Year Follow up Results
Table 3: XIENCE V (PROMUS) Spirit III Trial, Three Year Results
Table 4: XIENCE V (PROMUS) Spirit III Trial, in Diabetic Patients
Table 5: Peripheral Vascular Devices, Global, Revenue ($m), 2000-2015
Table 6: Prosthetic Heart Valve, Global, Revenue ($m), 2000-2015
Table 7: Ventricular Assist Devices, Global, Revenue ($m), 2000-2015
Table 8: FISH closure device Clinical Trial Details
Table 9: USD to Local Currency, Average Exchange Rate 2008
1.2 LIST OF FIGURES
Figure 1: Interventional Cardiology, Global, Revenue ($m), 2000-2015
Figure 2: Interventional Cardiology, Company Shares, 2009
Figure 3: Peripheral Vascular Devices, Global, Revenue ($m), 2000-2015
Figure 4: Peripheral Vascular Device, Company Shares, 2009
Figure 5: Prosthetic Heart Valve, Global, Revenue ($m), 2000-2015
Figure 6: Ventricular Assist Devices, Global, Revenue ($m), 2000-2015
Figure 7: GlobalData Methodology
Morris Innovative
ProSolv CardioVascular
TeraRecon, Inc.
Ardian Inc.
PLC Systems Inc.
Vascular Solutions
